Ausgabe 3/2020
Inhalt (13 Artikel)
Advanced therapy medicinal products: value judgement and ethical evaluation in health technology assessment
Elisabete Gonçalves
Survival and costs of colorectal cancer treatment and effects of changing treatment strategies: a model approach
Paal Joranger, Arild Nesbakken, Halfdan Sorbye, Geir Hoff, Arne Oshaug, Eline Aas
Cost-effectiveness analysis of the Neuropad device as a screening tool for early diabetic peripheral neuropathy
B. Rodríguez-Sánchez, L. M. Peña-Longobardo, A. J. Sinclair
Unfolding the relationship between mortality, economic fluctuations, and health in Italy
Maddalena Cavicchioli, Barbara Pistoresi
The societal monetary value of a QALY associated with EQ-5D-3L health gains
Laura Vallejo-Torres, Borja García-Lorenzo, Oliver Rivero-Arias, José Luis Pinto-Prades
Non-compensatory aggregation method to measure social and material deprivation in an urban area: relationship with premature mortality
Carolina Bruzzi, Enrico Ivaldi, Stefano Landi
Health state utilities associated with treatment for transfusion-dependent β-thalassemia
Louis S. Matza, L. Clark Paramore, Katie D. Stewart, Hayley Karn, Minesh Jobanputra, Andrew C. Dietz
Austerity, healthcare provision, and health outcomes in Spain
Cristina Borra, Jerònia Pons-Pons, Margarita Vilar-Rodríguez
Once bitten, twice shy? Lessons learned from an experiment to liberalize price regulations for dental care
Anna-Lena Trescher, Stefan Listl, Onno van der Galien, Frank Gabel, Olivier Kalmus
Cost-effectiveness and budget impact of the microprocessor-controlled knee C-Leg in transfemoral amputees with and without diabetes mellitus
Alexander Kuhlmann, Henning Krüger, Susanne Seidinger, Andreas Hahn
Healthcare costs associated with breast cancer in Germany: a claims data analysis
Kristine Kreis, Marika Plöthner, Torben Schmidt, Richard Seufert, Katharina Schreeb, Veronika Jahndel, Sylke Maas, Alexander Kuhlmann, Jan Zeidler, Anja Schramm
A comparison of individual and collective decision making for standard gamble and time trade-off
Arthur E. Attema, Han Bleichrodt, Olivier l’Haridon, Stefan A. Lipman
Correction to: Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma
Laura Amanda Vallejo-Aparicio, Jesús Molina, Iñigo Ojanguren, Ana Viejo Casas, Alicia Huerta, Henrik Svedsater